Next Article in Journal
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study
Next Article in Special Issue
Short- and Long-Term Visual Outcomes in Patients Receiving Intravitreal Injections: The Impact of the Coronavirus 2019 Disease (COVID-19)—Related Lockdown
Previous Article in Journal
Grip Strength in Patients with Gastrointestinal Diseases
Previous Article in Special Issue
Complete Resolution of Central Soft Drusen without Geographic Atrophy or Choroidal Neovascularization
 
 
Review

Article Versions Notes

J. Clin. Med. 2022, 11(8), 2083; https://doi.org/10.3390/jcm11082083
Action Date Notes Link
article html file updated 22 August 2026 01:29 CEST Update https://www.mdpi.com/2077-0383/11/8/2083/html
article html file updated 10 September 2025 14:34 CEST Update -
article html file updated 2 August 2022 17:44 CEST Update -
article html file updated 7 April 2022 14:58 CEST Update -
article pdf uploaded. 7 April 2022 14:57 CEST Updated version of record https://www.mdpi.com/2077-0383/11/8/2083/pdf
article xml uploaded. 7 April 2022 14:57 CEST Update https://www.mdpi.com/2077-0383/11/8/2083/xml
article xml file uploaded 7 April 2022 14:56 CEST Update -
article html file updated 7 April 2022 14:19 CEST Original file -
article pdf uploaded. 7 April 2022 14:17 CEST Version of Record -
article xml uploaded. 7 April 2022 14:17 CEST Update -
article xml file uploaded 7 April 2022 14:17 CEST Original file -
Back to TopTop